微创体外循环与常规体外循环在心脏手术中的系统综述与荟萃分析
该系统综述与荟萃分析纳入36项随机对照试验共4849例患者,比较微创体外循环(MiECC)与常规体外循环(cCPB)在心脏手术中的效果。结果显示MiECC显著降低死亡率、术后心肌梗死和脑血管事件风险,并减少输血需求、失血量、因出血再探查率及房颤发生率,缩短机械通气、ICU和住院时间。
要点
- MiECC显著降低心脏手术后死亡率(OR 0.66)。
- MiECC减少术后心肌梗死和脑血管事件风险。
- MiECC减少输血需求、失血、再探查及房颤,缩短通气与住院时间。
核心结论
- MiECC可降低心脏手术后发病率和死亡率,提示应更广泛采用该技术。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus和Cochrane数据库及主要会议论文集至2024年8月31日。
- 纳入36项符合预设MiECC标准的随机对照试验,共4849例患者。
- 主要结局为死亡率,次要结局为发病率和输血需求,使用Cochrane RoB 2工具评估偏倚风险。
主要发现
- MiECC组死亡率显著降低(OR 0.66;95%CI 0.53-0.81;P=0.0002;I2=0%)。
- MiECC组术后心肌梗死风险显著降低(OR 0.42;95%CI 0.26-0.68;P=0.002;I2=0%)。
- MiECC组脑血管事件风险显著降低(OR 0.55;95%CI 0.37-0.80;P=0.007;I2=0%)。
- MiECC减少红细胞输血需求、失血量、因出血再探查率及房颤发生率。
- MiECC显著缩短机械通气时间、ICU停留时间和住院时间。
临床怎么用
- 在符合MiECC标准的心脏手术中,可考虑采用MiECC以降低死亡率和术后并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The question whether minimally invasive extracorporeal circulation (MiECC) represents the optimal perfusion strategy in cardiac surgery remains unanswered. We sought to systematically review the entire literature and thoroughly address the impact of MiECC versus conventional cardiopulmonary bypass (cCPB) on adverse clinical outcomes after cardiac surgery. METHODS: We searched PubMed, Scopus and Cochrane databases for appropriate articles as well as conference proceedings from major congresses up to 31 August 2024. All randomized controlled trials (RCTs) that fulfilled pre-defined MiECC criteria were included in the analysis. The primary outcome was mortality, while morbidity and transfusion requirements were secondary outcomes. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool. All studies meeting the outcomes of interest of this systematic review were eligible for synthesis. RESULTS: Of the 738 records identified, 36 RCTs were included in the meta-analysis with a total of 4849 patients. MiECC was associated with significantly reduced mortality [odds ratio (OR) 0.66; 95% confidence interval (CI) 0.53-0.81; P = 0.0002; I2 = 0%] as well as risk of postoperative myocardial infarction (OR 0.42; 95% CI 0.26-0.68; P = 0.002; I2 = 0%) and cerebrovascular events (OR 0.55; 95% CI 0.37-0.80; P = 0.007; I2 = 0%). Moreover, MiECC reduced RBC transfusion requirements, blood loss and rate of re-exploration for bleeding together with incidence of atrial fibrillation. This resulted in significantly reduced duration of mechanical ventilation, ICU and hospital stay. CONCLUSIONS: This meta-analysis provides robust evidence for the beneficial effect of MiECC in reducing postoperative morbidity and mortality after cardiac surgery and prompts for a wider adoption of this technology.
引用
- Anastasiadis K, Antonitsis P, Voucharas C, et al. Minimal invasive extracorporeal circulation versus conventional cardiopulmonary bypass in cardiac surgery: a contemporary systematic review and meta-analysis. Eur J Cardiothorac Surg. 2025. PMID: 40131383. doi:10.1093/ejcts/ezaf112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。